Ontozry is an epilepsy medicine for treating epileptic fits starting in one specific part of the brain (focal seizures), including those that eventually spread to the whole brain (secondary generalisation). Ontozry is used as an add-on to other epilepsy medicines for adults with seizures that are not controlled despite having tried at least two other treatments. It contains the active substance cenobamate.
Therapeutic Indication
### Therapeutic indication Adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.
Therapeutic Area (MeSH)
N/AATC Code
N03AX
ATC Item
其它抗癫痫药
Pharmacotherapeutic Group
Antiepileptics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| cenobamate | N/A | Cenobamate |
EMA Name
Ontozry
Medicine Name
Ontozry
Aliases
N/ANo risk management plan link.
